These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7807931)

  • 41. Sudden death with cardiac involvement in a neonate with carnitine-acylcarnitine translocase deficiency.
    Jing J; Zhang C; Du S; Tan X; Yue X; Qiao D
    Cardiovasc Pathol; 2024; 70():107630. PubMed ID: 38490313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency.
    Hsu BY; Iacobazzi V; Wang Z; Harvie H; Chalmers RA; Saudubray JM; Palmieri F; Ganguly A; Stanley CA
    Mol Genet Metab; 2001; 74(1-2):248-55. PubMed ID: 11592821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carnitine-acylcarnitine translocase deficiency is a treatable disease.
    al Aqeel AI; Rashed MS; Wanders RJ
    J Inherit Metab Dis; 1999 May; 22(3):271-5. PubMed ID: 10384385
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical and molecular characteristics of carnitine-acylcarnitine translocase deficiency: Experience with six patients in Guangdong China.
    Tang C; Liu S; Wu M; Lin S; Lin Y; Su L; Zhang J; Feng Y; Huang Y
    Clin Chim Acta; 2019 Aug; 495():476-480. PubMed ID: 31108048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carnitine-acylcarnitine translocase deficiency caused by
    Zhang L; Hu Y; Xie M; Zhang Y; Cen K; Chen L; Cui Y; Li H; Wang D
    J Int Med Res; 2023 Apr; 51(4):3000605231163811. PubMed ID: 37115522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel method for determining peroxisomal fatty acid β-oxidation.
    Morita M; Matsumoto S; Okazaki A; Tomita K; Watanabe S; Kawaguchi K; Minato D; Matsuya Y; Shimozawa N; Imanaka T
    J Inherit Metab Dis; 2016 Sep; 39(5):725-731. PubMed ID: 27324171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carnitine-acylcarnitine translocase deficiency. Clinical course of 3 Saudi children with a severe phenotype.
    Al-Mendalawi MD
    Saudi Med J; 2011 Feb; 32(2):203; author reply 203. PubMed ID: 21301774
    [No Abstract]   [Full Text] [Related]  

  • 48. Ethnic-specific splicing mutation of the carnitine-acylcarnitine translocase gene in a Chinese neonate presenting with sudden unexpected death.
    Lam CW; Lai CK; Chow CB; Tong SF; Yuen YP; Mak YF; Chan YW
    Chin Med J (Engl); 2003 Jul; 116(7):1110-2. PubMed ID: 12890396
    [No Abstract]   [Full Text] [Related]  

  • 49. Functional analysis of mutations in the human carnitine/acylcarnitine translocase in Aspergillus nidulans.
    Pérez P; Martínez O; Romero B; Olivas I; Pedregosa AM; Palmieri F; Laborda F; Ramón De Lucas J
    Fungal Genet Biol; 2003 Aug; 39(3):211-20. PubMed ID: 12892634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.
    Wang GL; Wang J; Douglas G; Browning M; Hahn S; Ganesh J; Cox S; Aleck K; Schmitt ES; Zhang W; Wong LJ
    Mol Genet Metab; 2011 Aug; 103(4):349-57. PubMed ID: 21605995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissecting the spectrum of fatty acid oxidation disorders.
    Stanley CA
    J Pediatr; 1998 Mar; 132(3 Pt 1):384-6. PubMed ID: 9544886
    [No Abstract]   [Full Text] [Related]  

  • 52. Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review.
    Yan HM; Hu H; Ahmed A; Feng BB; Liu J; Jia ZJ; Wang H
    Medicine (Baltimore); 2017 Nov; 96(45):e8549. PubMed ID: 29137068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lethal cardiac tachyarrhythmia in a patient with neonatal carnitine-acylcarnitine translocase deficiency.
    Choong K; Clarke JT; Cutz E; Pollit RJ; Olpin SE
    Pediatr Dev Pathol; 2001; 4(6):573-9. PubMed ID: 11826365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
    Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
    Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The structure and organization of the human carnitine/acylcarnitine translocase (CACT1) gene2.
    Iacobazzi V; Naglieri MA; Stanley CA; Wanders RJ; Palmieri F
    Biochem Biophys Res Commun; 1998 Nov; 252(3):770-4. PubMed ID: 9837782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carnitine-acylcarnitine translocase deficiency--a mild phenotype.
    Olpin SE; Bonham JR; Downing M; Manning NJ; Pollitt RJ; Sharrard MJ; Tanner MS
    J Inherit Metab Dis; 1997 Sep; 20(5):714-5. PubMed ID: 9323572
    [No Abstract]   [Full Text] [Related]  

  • 57. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria.
    Lamhonwah AM; Tein I
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1315-25. PubMed ID: 16729965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carnitine-acylcarnitine translocase deficiency. Clinical course of three Saudi children with a severe phenotype.
    Al-Sannaa NA; Cheriyan GM
    Saudi Med J; 2010 Aug; 31(8):931-4. PubMed ID: 20714679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats.
    Paradies G; Ruggiero FM; Petrosillo G; Quagliariello E
    FEBS Lett; 1996 Nov; 397(2-3):260-2. PubMed ID: 8955359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.